An investor in NASDAQ:ITCI shares filed a lawsuit over alleged violations of Federal Securities Laws by Intra-Cellular Therapies Inc. Investors who purchased shares of Intra-Cellular Therapies Inc (NASDAQ:ITCI) should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554. The plaintiff claims that between August 12, 2014 through April 28, 2017, the defendants […]
Why Data Security is of Paramount Importance
Data or Information security is the top most priority for almost all business sector organizations, and even local computer users need to preserve their data from theft or loss. Useful information, payment details, personal stuff, bank details these all are worthful from business and personal point of view, and it causes severe damage if it […]
NASDAQ:AMGN Investor News: Investigation of Amgen, Inc. announced
An investigation was announced for investors in NASDAQ:AMGN shares over potential securities laws violations by Amgen, Inc.. Investors who purchased shares of Amgen, Inc. (NASDAQ:AMGN), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554. The investigation by a law firm focuses on whether a series of statements […]
NYSE: Why Real Estate Stocks Will Prosper in the Next Five Years
At the beginning of 2017, CNBC announced that real estate stock was “underowned”. In fact, that was an understatement, as this stock was being completely ignored. These days it seems like investors want to sink their money into tech, gold, mining and currencies like Bitcoin. They are less enthusiastic about brick-and-mortar, even though this industry […]
Stallone wishes luck to the Indian remake team of Rambo on Twitter
Sylvester Stallone immortalized his character in the cult legend, Rambo. No wonder, then, why Bollywood plans on replicating this success by making its official remake. Directed by Sidharth Anand, the remake is set to star the Indian actor, Tiger Shroff, in the lead role of Rambo. The film was recently announced at the Cannes Film […]
NASDAQ:EXAS Investor News: Investigation over potential Wrongdoing at EXACT Sciences Corporation
An investigation was announced for investors in NASDAQ:EXAS shares concerning potential breaches of fiduciary duties by certain officers and directors at EXACT Sciences. Investors who purchased shares of EXACT Sciences Corporation (NASDAQ:EXAS) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554. The investigation by a law firm […]
- « Previous Page
- 1
- …
- 90
- 91
- 92
- 93
- 94
- …
- 12140
- Next Page »